Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127168121 | 12716812 | 1 | I | 20160822 | 20160906 | 20160906 | PER | US-ELI_LILLY_AND_COMPANY-US201608011133 | ELI LILLY AND CO | 0.00 | M | Y | 106.00000 | KG | 20160906 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127168121 | 12716812 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 60 MG, UNK | U | U | 21427 | 60 | MG | CAPSULE | QD | ||||
127168121 | 12716812 | 2 | C | LYRICA | PREGABALIN | 1 | UNK MG, QD | 0 | QD | ||||||||||
127168121 | 12716812 | 3 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0 | ||||||||||||
127168121 | 12716812 | 4 | C | MORPHINE | MORPHINE | 1 | 0 | ||||||||||||
127168121 | 12716812 | 5 | C | TIZANIDINE. | TIZANIDINE | 1 | 0 | ||||||||||||
127168121 | 12716812 | 6 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127168121 | 12716812 | 1 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127168121 | 12716812 | Insomnia | |
127168121 | 12716812 | Pain | |
127168121 | 12716812 | Paraesthesia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |